Pulmuone Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Pulmuone.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Food earnings growth	14.8%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

Recent updates

We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Mar 27

Is Now An Opportune Moment To Examine Pulmuone Co., Ltd. (KRX:017810)?

Apr 13

There Are Reasons To Feel Uneasy About Pulmuone's (KRX:017810) Returns On Capital

Mar 26

Pulmuone Co., Ltd. (KRX:017810) Is Yielding 0.6% - But Is It A Buy?

Mar 08

Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

Feb 18

Does Pulmuone's (KRX:017810) Share Price Gain of 57% Match Its Business Performance?

Jan 31

Based On Its ROE, Is Pulmuone Co., Ltd. (KRX:017810) A High Quality Stock?

Jan 13

When Should You Buy Pulmuone Co., Ltd. (KRX:017810)?

Dec 26

Key Things To Watch Out For If You Are After Pulmuone Co., Ltd.'s (KRX:017810) 0.6% Dividend

Dec 08

These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Nov 20

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Pulmuone has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSE:A017810 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	2,993,468	9,365	66,157	193,580	N/A
9/30/2023	2,958,921	-32,906	50,932	175,042	N/A
6/30/2023	2,967,237	-29,460	29,972	163,685	N/A
3/31/2023	2,917,752	-26,360	-26,700	119,173	N/A
12/31/2022	2,838,304	-29,957	-54,529	92,256	N/A
9/30/2022	2,752,559	-1,547	-96,461	102,996	N/A
6/30/2022	2,659,691	-786	-97,638	104,899	N/A
3/31/2022	2,588,871	-3,820	-114,780	105,871	N/A
12/31/2021	2,518,896	5,326	-104,573	118,483	N/A
9/30/2021	2,457,293	12,577	-63,175	120,492	N/A
6/30/2021	2,399,108	12,989	-78,237	101,972	N/A
3/31/2021	2,329,175	17,542	-26,907	119,900	N/A
12/31/2020	2,311,200	14,880	-45,707	103,961	N/A
9/30/2020	2,339,353	15,663	-61,553	84,400	N/A
6/30/2020	2,362,839	13,047	-33,498	108,378	N/A
3/31/2020	2,394,780	15,121	-59,803	86,106	N/A
12/31/2019	2,381,451	2,092	-41,900	85,410	N/A
9/30/2019	2,341,499	12,708	-8,649	107,434	N/A
6/30/2019	2,300,882	15,531	-17,709	74,623	N/A
3/31/2019	2,276,085	15,987	-14,116	77,653	N/A
12/31/2018	2,271,973	20,448	-37,886	59,291	N/A
9/30/2018	2,257,209	24,953	-47,932	42,099	N/A
6/30/2018	2,244,986	29,473	-62,242	53,537	N/A
3/31/2018	2,222,750	35,628	-67,181	45,481	N/A
12/31/2017	2,195,658	38,506	-47,407	62,648	N/A
9/30/2017	2,182,182	42,149	N/A	59,331	N/A
6/30/2017	2,134,206	36,862	N/A	47,607	N/A
3/31/2017	2,089,078	20,413	N/A	60,222	N/A
12/31/2016	2,030,673	18,595	N/A	57,937	N/A
9/30/2016	1,963,638	20,184	N/A	54,603	N/A
6/30/2016	1,917,451	12,666	N/A	66,996	N/A
3/31/2016	1,874,813	19,773	N/A	38,453	N/A
12/31/2015	1,846,488	20,319	N/A	106,415	N/A
9/30/2015	1,822,004	58,819	N/A	121,686	N/A
6/30/2015	1,789,627	60,187	N/A	118,992	N/A
3/31/2015	1,743,290	57,841	N/A	144,260	N/A
12/31/2014	1,678,094	55,023	N/A	82,174	N/A
9/30/2014	1,615,684	-5,251	N/A	78,694	N/A
6/30/2014	1,565,074	-3,726	N/A	100,735	N/A
3/31/2014	1,538,641	-6,555	N/A	99,135	N/A
12/31/2013	1,521,708	-6,299	N/A	111,377	N/A
9/30/2013	1,501,571	6,394	N/A	99,935	N/A
6/30/2013	1,490,743	9,633	N/A	82,627	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A017810's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if A017810's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A017810's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A017810's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A017810's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A017810's Return on Equity is forecast to be high in 3 years time

Pulmuone Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Price target decreased to ₩19,000

Consensus forecasts updated

Consensus forecasts updated

Consensus forecasts updated

Recent updates

High number of new directors

We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Upcoming dividend of ₩102 per share at 1.0% yield

New major risk - Revenue and earnings growth

Full year 2022 earnings released: ₩724 loss per share (vs ₩145 profit in FY 2021)

Upcoming dividend of ₩102 per share

Third quarter 2022 earnings released: EPS: ₩298 (vs ₩293 in 3Q 2021)

Insufficient new directors

Price target decreased to ₩19,000

Insufficient new directors

Insufficient new directors

Upcoming dividend of ₩102 per share

Consensus forecasts updated

Consensus forecasts updated

Consensus forecasts updated

Investor sentiment improved over the past week

Is Now An Opportune Moment To Examine Pulmuone Co., Ltd. (KRX:017810)?

There Are Reasons To Feel Uneasy About Pulmuone's (KRX:017810) Returns On Capital

Full year 2020 earnings released: EPS ₩399 (vs ₩56.00 in FY 2019)

Pulmuone Co., Ltd. (KRX:017810) Is Yielding 0.6% - But Is It A Buy?

Pulmuone Co., Ltd., Annual General Meeting, Mar 25, 2021

Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

Does Pulmuone's (KRX:017810) Share Price Gain of 57% Match Its Business Performance?

Based On Its ROE, Is Pulmuone Co., Ltd. (KRX:017810) A High Quality Stock?

New 90-day high: ₩18,650

When Should You Buy Pulmuone Co., Ltd. (KRX:017810)?

Upcoming Dividend of ₩102 Per Share

Key Things To Watch Out For If You Are After Pulmuone Co., Ltd.'s (KRX:017810) 0.6% Dividend

These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Pulmuone Co., Ltd. (KOSE:A017810) agreed to acquire 51% stake in Pulmuone Waters Co., Ltd. from Nestlé S.A. (SWX:NESN) for KRW 36 billion.

New 90-day low: ₩15,600

New 90-day low: ₩16,400

New 90-day high - ₩21,200

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies